Newsletter – November 2019

NEWSLETTER NOVEMBER 2019

CLINICAL TRIAL NEWS

Take a Break and Read our Clinical Trial News!

About IDDI
Biostatistical Services
eClinical Services
CONTACT US
USING DISEASE FREE SURVIVAL (DFS) AS A PRIMARY ENDPOINT IN EARLY BREAST CANCER

IDDI in collaboration with Roche have identified why using disease-free survival as a primary endpoint in early breast cancer is the way forward!

READ ARTICLE HERE

Study designBAYESIAN OUTCOME-ADAPTIVE RANDOMIZATION DESIGNS: A PROMISE NOT WITHOUT PERIL

Learn on the principles of OAR designs – The key considerations for implementing Bayesian OAR designs and potential challenges ahead – The impact of selected elements of OAR designs on operational characteristics of a clinical trial – The advantages and disadvantages of OAR designs.

ON-DEMAND WEBINAR AVAILABLE HERE

TALENT SPOTLIGHT
ELS COART, Senior Biostatistician, Biomarker Development, IDDIElisabeth (Els) Coart, M.Sc, PhD, Director, Consulting Services

Els joined IDDI in 2011, initially for research work related to biomarkers in Alzheimer’s disease. She has a strong background in assay development combined with 10 years’ experience as statistician for biotech and diagnostic industries. Over the past several years, Els has gained comprehensive experience in study design for oncology and has become IDDI’s expert in analytical and clinical validation of (companion) diagnostics, or IVDs. She has represented IDDI in symposia, publications, and countless interactions with prospects and clients. Els shares her high level of expertise with our team of consultants and has been instrumental in making this team grow over the last couple of years.

 
FAST GROWING COMPANY
OPENING OF A SECOND EUROPEAN OFFICE

IDDI has opened a new office in Mont-Saint-Guibert, Belgium to accommodate accelerated growth. This new location houses up to 40 additional employees.

Clinical Trial Management - IDDIMORE THAN 20 NEW EMPLOYEES SINCE BEGINNING OF THE YEAR

Interested in joining us? View our career page! Tremendous opportunities in Belgium and in the US. Apply today!

VIEW OUR CAREER PAGE

UPCOMING EVENTS

We look forward to meeting you at one of those following events!

CONFERENCE & MEETINGSWEBINAR & PRESENTATIONS
9ème Journée de la Recherche Clinique
Paris, France, January 30, 20205th Annual Biomarker & Companion Diagnostics
San Diego, CA, USA, February 6-7

5th European Conference on Clinical Research
Amsterdam, The Netherlands, February 10-11

Clinical Operations in Oncology Trials Southern California 2020
San Diego, CA, USA February 12-13

DIA Europe
Brussels, Belgium, March 17-20

BIO-EUROPE SPRING
Paris, France, March 23-25

MassBio’s Annual Meeting
Boston, MA, USA, March 25 – 26, 2020

Outsourcing in Clinical Trials Southeast
Durham, NC, USA, March 31-April 1, 2020

Validating Surrogate Endpoints in Oncology: From Theory to Practice!

On-demand presentations and recording

Bayesian Outcome-Adaptive Designs: A promise not without Peril

On-demand webinar

Expansion Cohorts in Early Development of Anticancer Agents

On-demand webinar

Assessing Treatment Benefit in Immuno-Oncology

On-demand webinar

A New Statistical Method: Generalized Pairwise Comparisons

On-demand webinar

Treatment Allocation in Randomized Trials: Challenges and Best Practices
On-demand webinar

VIEW MORE EVENTS VIEW MORE ON-DEMAND WEBINARS 

 

 COMBINING PASSION SCIENCE AND EXPERIENCE
TO ENSURE YOUR CLINICAL DATA IS READY FOR SUBMISSIONIDDI is a biostatistical and eClinical services provider offering Trial DesignRandomizationData Management and Biostatistics services for Pharmaceutical and Biotech companies.
IDDI (International Drug Development Institute)
Serge Bodart – Chief Commercial Officer
serge.bodart@iddi.com
Direct: +1 514 909 0134 – +32 10 62 15 01

 

Powered by Atypic ®

IDDI